AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as Companion Diagnostic for TEPMETKO® (Tepotinib)

Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., and Precision Medicine Asia Co., Ltd. announced that the Ministry of Health, Labour and Welfare has approved the AmoyDx^® Pan Lung Cancer PCR Panel as a companion diagnostic for TEPMETKO^® a Merck KGaA, Darmstadt, Germany product that received approval by the Japanese MHLW in March 2020.